Chapter 3 - Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50-D89)»Other disorders of blood and blood-forming organs (D70-D77)»Myelofibrosis (D75.81)
D75.81
Myelofibrosis
Related indications (MeSH) (1)
Primary Myelofibrosis232 drugs (126 approved, 106 experimental)
A de novo myeloproliferation arising from an abnormal stem cell. It is characterized by the replacement of bone marrow by fibrous tissue, a process that is mediated by CYTOKINES arising from the abnormal clone.